Dauri 2003.
| Methods | RCT Written informed consent obtained Setting: Italy Funding: unspecified |
|
| Participants | 25 patients undergoing cadaveric renal transplantation | |
| Interventions |
Treatment group: TEA (T12‐L1) with ropivacaine 0.2% and fentanyl 2 mcg/mL for 24 hours (n = 13) Control group: IV tramadol (n = 12) |
|
| Outcomes | VAS at rest at 6 and 24 hours VAS on movement at 6 and 24 hours Hospital LOS |
|
| Notes | ||
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Unclear risk | "randomly allocated into two groups", no details |
| Allocation concealment (selection bias) | Unclear risk | Not mentioned |
| Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | Not mentioned |
| Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Not mentioned |
| Incomplete outcome data (attrition bias) All outcomes | Low risk | No loss to follow‐up mentioned |
| Selective reporting (reporting bias) | Low risk | All results reported |
| Other bias | Low risk | Groups well balanced |